{"title":"Brain functional connectivity analysis of fMRI-based Alzheimer's disease data.","authors":"Maitha S Alarjani, Badar A Almarri","doi":"10.3389/fmed.2025.1540297","DOIUrl":null,"url":null,"abstract":"<p><p>The prevalence of Alzheimer's disease (AD) poses a significant public health challenge. Distinguishing AD stages remains a complex process due to ambiguous variability within and across AD stages. Manual classification of such multifaceted and massive data of brain volumes is operationally inefficient and vulnerable to human errors. Here, we propose a precise and systematic framework for AD stages classification. The core of this framework discovers and analyzes functional connectivity among regions of interest (ROIs) of a human brain. Multivariate Pattern Analysis (MVPA) is applied to extract features that reveal complex functional connectivity patterns in the brain. These features are then used as inputs for an Extreme Learning Machine (ELM) model to classify AD stages. The model's performance is assessed through comprehensive evaluation metrics to ensure robustness and reliability. Applying this framework on datasets which contain meticulously validated fMRI scans such as the OASIS and AD Neuroimaging Initiative datasets, we validate the merit of this proposed work. The framework's results show improvement in the collective performance of two-class and multi-class classification. Feeding ELM with MVPA features yield decent outcomes given a generalizable and computationally-efficient model. This study underscores the effectiveness of the proposed approach in accurately distinguishing AD stages, offering potential improvements in AD and AD stages detection.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1540297"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880024/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1540297","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
The prevalence of Alzheimer's disease (AD) poses a significant public health challenge. Distinguishing AD stages remains a complex process due to ambiguous variability within and across AD stages. Manual classification of such multifaceted and massive data of brain volumes is operationally inefficient and vulnerable to human errors. Here, we propose a precise and systematic framework for AD stages classification. The core of this framework discovers and analyzes functional connectivity among regions of interest (ROIs) of a human brain. Multivariate Pattern Analysis (MVPA) is applied to extract features that reveal complex functional connectivity patterns in the brain. These features are then used as inputs for an Extreme Learning Machine (ELM) model to classify AD stages. The model's performance is assessed through comprehensive evaluation metrics to ensure robustness and reliability. Applying this framework on datasets which contain meticulously validated fMRI scans such as the OASIS and AD Neuroimaging Initiative datasets, we validate the merit of this proposed work. The framework's results show improvement in the collective performance of two-class and multi-class classification. Feeding ELM with MVPA features yield decent outcomes given a generalizable and computationally-efficient model. This study underscores the effectiveness of the proposed approach in accurately distinguishing AD stages, offering potential improvements in AD and AD stages detection.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world